<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Toxics</journal-id><journal-id journal-id-type="iso-abbrev">Toxics</journal-id><journal-id journal-id-type="publisher-id">toxics</journal-id><journal-title-group><journal-title>Toxics</journal-title></journal-title-group><issn pub-type="epub">2305-6304</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39997941</article-id><article-id pub-id-type="pmc">PMC11860847</article-id>
<article-id pub-id-type="doi">10.3390/toxics13020126</article-id><article-id pub-id-type="publisher-id">toxics-13-00126</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Interactions Between BMP2/BMP4 Gene Polymorphisms and Fluoride Exposure on Essential Hypertension: A Cross-Sectional Study in China</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Yue</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/visualization/">Visualization</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Qingbo</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="https://credit.niso.org/contributor-roles/formal-analysis/">Formal analysis</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="https://credit.niso.org/contributor-roles/resources/">Resources</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wu</surname><given-names>Junhua</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="https://credit.niso.org/contributor-roles/investigation/">Investigation</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yang</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xin</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Software" vocab-term-identifier="https://credit.niso.org/contributor-roles/software/">Software</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Yanhui</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref><xref rid="c1-toxics-13-00126" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yanmei</given-names></name><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x02013; review &#x00026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x02013; review &#x00026; editing</role><role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="https://credit.niso.org/contributor-roles/supervision/">Supervision</role><xref rid="af1-toxics-13-00126" ref-type="aff">1</xref><xref rid="af2-toxics-13-00126" ref-type="aff">2</xref><xref rid="c1-toxics-13-00126" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Tranfo</surname><given-names>Giovanna</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-toxics-13-00126"><label>1</label>Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, No. 157 Baojian Road, Nangang District, Harbin 150081, China; <email>gao15663673888@163.com</email> (Y.G.); <email>wangqingbo0628@163.com</email> (Q.W.); <email>m13245380261@163.com</email> (X.W.)</aff><aff id="af2-toxics-13-00126"><label>2</label>Key Lab of Etiology and Epidemiology, Education Bureau of Heilongjiang Province, Ministry of Health of P. R. China, Harbin Medical University, Harbin 150081, China</aff><author-notes><corresp id="c1-toxics-13-00126"><label>*</label>Correspondence: <email>gaoyanhui@hrbmu.edu.cn</email> (Y.G.); <email>yangym0916@163.com</email> (Y.Y.)</corresp></author-notes><pub-date pub-type="epub"><day>08</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>13</volume><issue>2</issue><elocation-id>126</elocation-id><history><date date-type="received"><day>11</day><month>12</month><year>2024</year></date><date date-type="rev-recd"><day>27</day><month>1</month><year>2025</year></date><date date-type="accepted"><day>04</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>(1) Objective: To evaluate the relationship between fluoride exposure, interactions of BMP2/BMP4 gene polymorphisms, and fluoride exposure on essential hypertension. (2) Methods: A cross-sectional study was conducted among 725 participants in a high-fluoride region of Shanxi Province, China. Urinary fluoride concentrations were measured as indicators of fluoride exposure. Hypertension was diagnosed based on standard guidelines. BMP2 (rs1005464) and BMP4 (rs17563) polymorphisms were genotyped. Logistic regression and interaction models were performed to evaluate associations and interactions between fluoride exposure, gene polymorphisms, and hypertension. (3) Results: Higher urinary fluoride concentrations were significantly associated with an increased risk of hypertension, exhibiting a dose-dependent relationship. The rs1005464 (G &#x0003e; A) polymorphism of BMP2 was identified as a protective factor against hypertension in individuals with the AG + AA genotype. Significant interactions were observed between the BMP2 rs1005464 and BMP4 rs17563 polymorphisms, influencing hypertension risk. Additionally, both multiplicative and additive interactions between high fluoride exposure and the BMP4 rs17563 polymorphism were identified, highlighting the combined impact of environmental and genetic factors on hypertension. (4) Conclusions: Fluoride exposure is positively associated with hypertension. BMP2 gene polymorphisms affect the risk of hypertension, and BMP4 gene polymorphisms may modify the impact of fluoride on hypertension.</p></abstract><kwd-group><kwd>fluoride</kwd><kwd>hypertension</kwd><kwd>BMP2/4</kwd><kwd>single nucleotide polymorphism</kwd><kwd>gene-environment interaction</kwd></kwd-group><funding-group><award-group><funding-source>National Natural Science Foundation of China</funding-source><award-id>30972561</award-id></award-group><award-group><funding-source>National Key R&#x00026;D Program of China</funding-source><award-id>2022YFC2503000</award-id></award-group><funding-statement>This work was supported by the National Natural Science Foundation of China [30972561]; National Key R&#x00026;D Program of China [2022YFC2503000].</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-toxics-13-00126"><title>1. Introduction</title><p>Fluorine, a naturally abundant element [<xref rid="B1-toxics-13-00126" ref-type="bibr">1</xref>], exerts a multifaceted influence on human health, functioning as a double-edged sword. Within recommended limits, fluorine contributes positively to bone mineralization and enamel development [<xref rid="B2-toxics-13-00126" ref-type="bibr">2</xref>]. Conversely, excessive intake may result in fluorosis [<xref rid="B3-toxics-13-00126" ref-type="bibr">3</xref>], a condition that not only compromises bone tissues but also poses risks to non-osseous tissues, including the cardiovascular system [<xref rid="B4-toxics-13-00126" ref-type="bibr">4</xref>]. Epidemiological studies have indicated a potential link between fluorine exposure and cardiovascular dysfunction, with evidence suggesting a correlation between fluorine levels and blood pressure [<xref rid="B5-toxics-13-00126" ref-type="bibr">5</xref>]. Nevertheless, the nature of this association&#x02014;whether positive or negative&#x02014;remains contested and warrants further investigation.</p><p>Blood pressure is influenced by cardiac output and peripheral vascular resistance, with vascular resistance primarily determined by vessel diameter and blood viscosity. Vascular remodeling, characterized by vessel narrowing, wall stiffening, and loss of elasticity, is a key factor in the onset and progression of hypertension [<xref rid="B6-toxics-13-00126" ref-type="bibr">6</xref>]. Vascular calcification, involving the deposition of calcium salts in the vessel walls, is a crucial mechanism in vascular remodeling, leading to hardening and elasticity loss. Additionally, vascular calcification and bone metabolism disorders may share common risk factors and underlying mechanisms [<xref rid="B7-toxics-13-00126" ref-type="bibr">7</xref>]. Studies have shown that high fluoride exposure can disrupt bone metabolism [<xref rid="B8-toxics-13-00126" ref-type="bibr">8</xref>], as fluoride enhances growth factors in bone cells and promotes osteoblast production via activation of the Wnt signaling pathway [<xref rid="B9-toxics-13-00126" ref-type="bibr">9</xref>]. Bone morphogenetic proteins (BMPs), essential for osteoblast survival and differentiation, are implicated in this process. Research suggests that fluoride disrupts BMP expression, contributing to bone metabolism abnormalities [<xref rid="B10-toxics-13-00126" ref-type="bibr">10</xref>], and BMP family members are recognized as key regulators in vascular calcification, capable of inducing the differentiation of vascular smooth muscle cells into osteogenic or chondrogenic-like cells [<xref rid="B11-toxics-13-00126" ref-type="bibr">11</xref>]. Thus, BMPs could be important in cardiovascular disease or hypertension related to fluoride exposure.</p><p>Hypertension arises from the interaction between environmental and genetic factors. Among the most common heritable variations in humans are single nucleotide polymorphisms (SNPs), which represent DNA sequence polymorphisms caused by single nucleotide changes [<xref rid="B12-toxics-13-00126" ref-type="bibr">12</xref>]. Over 30 genes and 1400 SNPs have been frequently linked to blood pressure regulation [<xref rid="B13-toxics-13-00126" ref-type="bibr">13</xref>]. The BMP2/4 genes have been identified as potential candidates for genetic polymorphisms associated with hypertension. This study hypothesizes that specific polymorphisms in BMP2/4 may contribute to the susceptibility to hypertension, potentially modifying vascular function and response to environmental exposures such as fluoride [<xref rid="B14-toxics-13-00126" ref-type="bibr">14</xref>]. While many studies have suggested a relationship between fluoride exposure and hypertension risk, few have provided epidemiological evidence on the specific role of BMP2/4 gene polymorphisms in this association. To address this gap, we conducted a study in Luliang City, Shanxi Province, an area with high fluoride exposure, aiming to determine (1) the relationship between fluoride exposure and hypertension; and (2) whether fluoride exposure and BMP2/4 genes polymorphism have interaction effects on hypertension. Given the potential role of BMP signaling in vascular health and the increasing concern regarding environmental fluoride exposure, this research is timely and important. By identifying genetic markers that may predispose individuals to hypertension in the context of fluoride exposure, this study could inform future preventive strategies and therapeutic interventions targeting genetic risk factors for hypertension.</p></sec><sec id="sec2-toxics-13-00126"><title>2. Materials and Methods</title><sec id="sec2dot1-toxics-13-00126"><title>2.1. Data Source</title><p>In 2018, a cross-sectional study was conducted in three villages in L&#x000fc;liang City, Shanxi Province, where records of drinking water fluoride levels were available. A cluster sampling method was employed to select the villages. Trained staff administered standardized questionnaires and conducted clinical examinations for all participants. The standardized questionnaire collected information on demographic characteristics (age and sex) and lifestyle habits (such as alcohol consumption and smoking). Clinical examinations included measurements of blood pressure, height, and weight. Participants had to be (1) Han ethnicity, (2) aged 16 years or older, (3) residing continuously in the area for at least 10 years, and (4) providing informed consent to participate. Exclusion criteria were as follows: (1) individuals with missing samples or unmeasured indicators; (2) incomplete epidemiological data; (3) undetectable indicators; (4) other types of hypertension except essential hypertension; and (5) pregnant individuals. Participants aged &#x02265;60 years were classified as elderly. Individuals who smoked at least one cigarette per day (currently or in the past) were categorized as smokers, while those who consumed alcohol more than twice a week (currently or in the past) were categorized as drinkers. Body mass index (BMI) was calculated as weight (kg) divided by the square of height (m<sup>2</sup>). Based on the BMI classification for Asian populations [<xref rid="B15-toxics-13-00126" ref-type="bibr">15</xref>], participants were categorized as normal weight (BMI &#x0003c; 23.9) or overweight (BMI &#x02265; 24). All participants provided written informed consent.</p></sec><sec id="sec2dot2-toxics-13-00126"><title>2.2. Hypertension Diagnosis</title><p>Each participant&#x02019;s blood pressure was measured twice in a seated position using a mercury sphygmomanometer after resting for at least five minutes, with the average of the two measurements recorded. Hypertension was diagnosed according to the 2020 International Society of Hypertension Global Hypertension Practice Guidelines, defined as a systolic blood pressure (SBP) &#x02265; 140 mmHg and/or diastolic blood pressure (DBP) &#x02265; 90 mmHg [<xref rid="B16-toxics-13-00126" ref-type="bibr">16</xref>] or a history of hypertension medication use.</p></sec><sec id="sec2dot3-toxics-13-00126"><title>2.3. Urinary Fluoride (UF) Concentration Determination</title><p>Urine samples were stored at &#x02212;20 &#x000b0;C before analysis. The fluoride concentration in urine was quantified using a fluoride ion-selective electrode (Yingke Crystal Materials Co., Changsha, China), measuring two independent aliquots for each sample, with the average of the two measurements representing the final fluoride concentration. Urine samples were processed and analyzed following standardized methods (WS/T 89-2015, China [<xref rid="B17-toxics-13-00126" ref-type="bibr">17</xref>]).</p></sec><sec id="sec2dot4-toxics-13-00126"><title>2.4. Detection of Gene Locus Polymorphisms</title><p>A 5 mL blood sample was collected from the fasting arm vein and placed in an anticoagulant tube. After one hour at room temperature, the plasma was centrifuged at 3000 rpm for 10 min and then stored at &#x02212;80 &#x000b0;C for genomic DNA analysis. DNA samples with concentrations greater than 20 &#x003bc;g/mL were genotyped using multiplex PCR and sequencing techniques by Beijing Xinjiyuan Biotechnology Co., Ltd. (Beijing, China). The primer sequences were as follows:<list list-type="simple"><list-item><p>rs1005464: forward-5&#x02032;-GTTTCTGTGAACGTCTAACTTACC-3&#x02032;</p></list-item><list-item><p>reverse-5&#x02032;-AATCAGTTAGTGGCCTTAAGAAAG-3&#x02032;</p></list-item><list-item><p>extended-5&#x02032;-CTTTCTTAAGGCCACTAACTGATT-3&#x02032;</p></list-item><list-item><p>rs17563: forward-5&#x02032;- ATAAATGTTTATACGGTGGAAGCC-3&#x02032;</p></list-item><list-item><p>reverse-5&#x02032;-ATATGCTTTTTCTTTTCCCCTTCC-3&#x02032;</p></list-item><list-item><p>extended-5&#x02032;-GGAAGGGGAAAAGAAAAAGCATAT-3&#x02032;</p></list-item></list></p></sec><sec id="sec2dot5-toxics-13-00126"><title>2.5. Statistical Methods</title><p>This work included statistical analysis and visualizations utilizing SPSS 26.0 (IBM, Armonk, NY, USA) and RStudio (version 2023.03.0). The Kolmogorov&#x02013;Smirnov test was employed to evaluate the normality of continuous variables. For non-normally distributed data, the Mann&#x02013;Whitney U test was employed to detect differences between groups. Differences across groups for categorical data were assessed utilizing the chi-squared test. A binary logistic regression model was used to assess hypertension risk in the second, third, and fourth quartiles compared to the first quartile. The Hardy&#x02013;Weinberg equilibrium test was conducted for SNP loci. When the genotype frequency distribution in the control group adhered to the Hardy&#x02013;Weinberg equilibrium, it suggested that the sample population in this study was randomly selected and representative of the natural population. Genetic models were analyzed using SNPStats, an online software (<uri xlink:href="https://www.snpstats.net/start.htm">https://www.snpstats.net/start.htm</uri>, accessed on 10 December 2024). The Akaike information criterion (AIC) and Bayesian information criterion (BIC) are two widely used criteria for selecting the optimal model, with lower AIC and BIC values indicating the best genetic models for our population&#x02019;s SNP data. Binary logistic regression was further used to calculate hypertension risk across different populations and to analyze the combined effect of SNPs and varying urinary fluoride levels on hypertension risk. An additional binary logistic regression model was applied to assess the impact of two-SNP combinations on hypertension risk, incorporating the product term of the two loci to evaluate multiplicative interaction. Additive interaction between the two loci was evaluated by the relative excess risk due to interaction (RERI) and the synergy index (SI). A <italic toggle="yes">p</italic>-value &#x0003c; 0.05 was considered statistically significant.</p></sec></sec><sec sec-type="results" id="sec3-toxics-13-00126"><title>3. Results</title><sec sec-type="subjects" id="sec3dot1-toxics-13-00126"><title>3.1. Characteristics of the Participants</title><p>The research comprised 725 people, 238 of whom were male and 487 of whom were female. Among them, 368 individuals were diagnosed with hypertension. The distribution of gender between the hypertension and control groups was not significantly different. The hypertension group had significantly higher age, BMI, and urinary fluoride concentrations compared to the control group. No substantial variations in smoking and drinking status were seen between the hypertension and control groups. Additionally, higher age, BMI, and urinary fluoride concentrations were correlated with a higher likelihood of hypertension (see <xref rid="toxics-13-00126-t001" ref-type="table">Table 1</xref>). In addition, a comparison of characteristics was performed between the included and excluded participants from the 989 eligible subjects. No statistically significant differences were found in characteristics including age, gender, BMI, urinary fluoride concentration, smoking, and alcohol consumption between the two groups (see <xref rid="app1-toxics-13-00126" ref-type="app">Table S1</xref>).</p></sec><sec id="sec3dot2-toxics-13-00126"><title>3.2. The Relationship Between Urinary Fluoride Concentration and the Risk of Hypertension</title><p>The association between urinary fluoride levels and the risk of hypertension was assessed using logistic regression analysis. Specifically, for each 1 mg/L increase in urinary fluoride concentration, the risk of developing hypertension was found to escalate by a factor of 0.307. Furthermore, after adjusting for potential confounding factors, when urinary fluoride levels were categorized into quartiles within the model, the third and fourth quartiles exhibited a significantly increased risk of hypertension compared to the first quartile (defined as &#x0003c;0.87 mg/L) (OR = 1.513 and OR = 1.647, respectively). Moreover, in the trend test, both before and after adjusting for confounding factors, the risk of hypertension increased with higher urinary fluoride concentrations (see <xref rid="toxics-13-00126-t002" ref-type="table">Table 2</xref>).</p></sec><sec id="sec3dot3-toxics-13-00126"><title>3.3. Associations of Risk of Hypertension and BMP2/BMP4 Genotype</title><p>The genotype frequency distribution in the control group adhered to the Hardy&#x02013;Weinberg equilibrium. We employed the SNPStats online software to examine the correlation between various genotypes and hypertension throughout five genetic models: codominant, dominant, recessive, overdominant, and log-additive. Analysis identified a significant association at the rs1005464 of the BMP2 and hypertension risk, with AIC and BIC criteria confirming a dominant inheritance pattern. The AG + AA genotype identified as a protective factor against hypertension. In contrast, the different genotypes of the rs17563 locus of the BMP4 gene did not show statistically significant associations with hypertension (see <xref rid="toxics-13-00126-t003" ref-type="table">Table 3</xref>).</p></sec><sec id="sec3dot4-toxics-13-00126"><title>3.4. Stratified Analysis by Potential Risk Factor of Hypertension</title><p>A statistically significant disparity in hypertension prevalence was discovered between the GG and the AG + AA genotype group at the rs1005464 (&#x003c7;<sup>2</sup> = 4.115). This difference was also evident among individuals younger than 60 years and among smokers (&#x003c7;<sup>2</sup> = 4.152 and &#x003c7;<sup>2</sup> = 9.179, respectively), as shown in <xref rid="toxics-13-00126-t004" ref-type="table">Table 4</xref>. A stratification analysis examined the association of rs1005464 with the risk of hypertension across subgroups defined by potential risk factors, including age, gender, BMI, urinary fluoride, cigarette smoking, and alcohol drinking, under the assumption of a dominant genetic model. The AG + AA genotype reduced the risk of prevalence of hypertension among individuals younger than 60 years (OR = 0.582), women (OR = 0.667), and alcohol drinkers (OR = 0.296). These results are shown in <xref rid="toxics-13-00126-t005" ref-type="table">Table 5</xref>.</p></sec><sec id="sec3dot5-toxics-13-00126"><title>3.5. Gene&#x02013;Gene Interactions on the Risk of Hypertension</title><p>The crossover analysis and interaction results between rs1005464 of BMP2 and rs17563 of BMP4 are indicated in <xref rid="toxics-13-00126-t006" ref-type="table">Table 6</xref>. Regardless of whether confounding factors were adjusted, multiplicative and additive (RERI = 0.77 and RERI = 1.13, respectively) interactions were observed between the two SNPs. After adjusting for confounding factors, the rs1005464 (GG) and rs17563 (AG + GG) combination was associated with an increased risk of hypertension compared to the reference combination of rs1005464 (AG + AA) and rs17563 (AA) (OR = 1.99) (see <xref rid="toxics-13-00126-t006" ref-type="table">Table 6</xref>).</p></sec><sec id="sec3dot6-toxics-13-00126"><title>3.6. Interactions Between Urinary Fluoride and Single Gene Polymorphism on the Hypertension Risk</title><p>High fluoride exposure and genotypes at rs17563 of the BMP4 gene exhibited both multiplicative and additive interactions (pre-adjustment RERI = &#x02212;1.35; post-adjustment RERI = &#x02212;1.38). After adjusting for confounders, the rs17563 (AG + GG) genotype combined with high fluoride exposure increased the risk of hypertension 1.21-fold compared to the reference group (rs17563 [AA] with high fluoride exposure, OR = 2.21) (see <xref rid="toxics-13-00126-t007" ref-type="table">Table 7</xref>). In contrast, no significant multiplicative or additive interactions were observed between UF and rs1005464 of BMP2 (<xref rid="toxics-13-00126-t008" ref-type="table">Table 8</xref>). However, after adjusting for confounders, high fluoride exposure combined with the rs1005464 (GG) genotype was associated with a 0.95-fold increased hypertension risk compared to the reference group (rs1005464 [AG + AA] with low fluoride, OR = 1.95).</p></sec></sec><sec sec-type="discussion" id="sec4-toxics-13-00126"><title>4. Discussion</title><p>Fluorine, the thirteenth most abundant element on Earth, is highly accessible to the human body due to its chemical properties and geographic mobility [<xref rid="B18-toxics-13-00126" ref-type="bibr">18</xref>]. Prior research suggests a potential link between fluoride exposure and an increased likelihood of vascular dysfunction and hypertension [<xref rid="B19-toxics-13-00126" ref-type="bibr">19</xref>]. Previous studies investigating the correlation between fluoride exposure and blood pressure have faced several limitations, including small sample sizes, inadequate case numbers, diverse types of fluoride exposure, numerous confounding factors, and inconsistent inclusion criteria for hypertension cases. These issues have resulted in conflicting findings, with reports of positive, negative, and null associations. In our study, we addressed these limitations by investigating residents of Wenshui County, L&#x000fc;liang City, Shanxi Province, who had lived in the area for at least 10 years, were of Han ethnicity, were aged 16 years or older, and had no other forms of hypertension. Potential confounding factors were rigorously controlled. Moreover, there were no statistically significant differences in the general characteristics between the included and excluded populations in this study, indicating that the study population is representative and can accurately reflect the target population. For this study, we selected urinary fluoride levels as an indicator of fluoride exposure. Regardless of whether urinary fluoride is analyzed as a continuous variable, a categorical variable, or analyzed for trend, the findings consistently demonstrate a statistically significant positive association between urinary fluoride concentration and hypertension prevalence. Notably, after adjusting for confounding factors, each 1 mg/L increase in urinary fluoride was associated with a 21% increase in hypertension risk. Additionally, urinary fluoride concentrations above 1.25 mg/L were linked to an elevated risk of hypertension, suggesting a dose-dependent effect with a potential threshold beyond which fluoride exposure may significantly raise blood pressure. This finding aligns with multiple animal studies supporting fluoride&#x02019;s impact on hypertension [<xref rid="B20-toxics-13-00126" ref-type="bibr">20</xref>,<xref rid="B21-toxics-13-00126" ref-type="bibr">21</xref>].</p><p>Bone morphogenetic proteins (BMPs), part of the TGF-&#x003b2; family, play key roles in regulating cell proliferation, differentiation [<xref rid="B22-toxics-13-00126" ref-type="bibr">22</xref>], and apoptosis [<xref rid="B23-toxics-13-00126" ref-type="bibr">23</xref>]. Dysregulated BMP signaling contributes to skeletal and cardiovascular diseases, including hypertension [<xref rid="B24-toxics-13-00126" ref-type="bibr">24</xref>]. BMP2 and BMP4 are particularly important in vascular smooth muscle cell (VSMC) trans-differentiation, a process that leads to the loss of muscle characteristics, increased expression of bone-related proteins, and vascular calcification, all of which are linked to hypertension [<xref rid="B25-toxics-13-00126" ref-type="bibr">25</xref>]. Polymorphisms in BMP2 and BMP4 genes, such as rs235756 (BMP2) and rs17563 (BMP4), have been associated with cardiovascular and skeletal diseases. A study on middle-aged Finnish men found a significant association between the BMP2 gene variant (rs235756) and the BMP4 gene variant (rs4901417) were associated with hypertension [<xref rid="B14-toxics-13-00126" ref-type="bibr">14</xref>].</p><p>This study focused on the rs17563 of the BMP4 gene and the rs1005464 of the BMP2 gene. The rs1005464 SNP is located in the non-coding region of BMP2 and is classified as an intronic variant. Its molecular and metabolic pathways have not yet been fully elucidated, but it may influence splicing patterns or affect the rate, efficiency, and accuracy of gene transcription [<xref rid="B26-toxics-13-00126" ref-type="bibr">26</xref>]. In this study, the rs1005464 was found to be associated with hypertension. Specifically, the GG genotype increases the risk of hypertension in women, non-elderly individuals, and alcohol drinkers. On the other hand, rs17563 of BMP4 is a missense variant that causes an amino acid substitution (V152A) [<xref rid="B27-toxics-13-00126" ref-type="bibr">27</xref>], potentially affecting mRNA stability, protein expression, and receptor binding affinity [<xref rid="B28-toxics-13-00126" ref-type="bibr">28</xref>], thereby altering BMP4 signaling [<xref rid="B29-toxics-13-00126" ref-type="bibr">29</xref>]. Our study demonstrated that interactions between rs17563 (BMP4) and rs235756 (BMP2) influence hypertension risk. BMP2 and BMP4 proteins share similar signaling pathways, activating Smad proteins that regulate gene expression [<xref rid="B30-toxics-13-00126" ref-type="bibr">30</xref>]. Their combined effects in VSMCs and endothelial cells may enhance cell proliferation and contractility, increase vascular resistance [<xref rid="B31-toxics-13-00126" ref-type="bibr">31</xref>], and promote hypertension [<xref rid="B32-toxics-13-00126" ref-type="bibr">32</xref>]. This synergistic interaction highlights the role of BMP-related genetic variations in hypertension pathogenesis.</p><p>Diseases are influenced by the combined effects of genetic and environmental factors. In this study, an interaction between the rs17563 polymorphism of the BMP4 gene and fluoride exposure was identified. Individuals with the AG + GG genotype and high fluoride exposure had over twice the risk of hypertension compared to those with the AA genotype and low fluoride exposure, suggesting a synergistic effect. The rs17563 polymorphism is associated with elevated serum BMP4 levels [<xref rid="B33-toxics-13-00126" ref-type="bibr">33</xref>], which contribute to vascular calcification [<xref rid="B34-toxics-13-00126" ref-type="bibr">34</xref>], endothelial dysfunction, and inflammation, all linked to hypertension [<xref rid="B35-toxics-13-00126" ref-type="bibr">35</xref>,<xref rid="B36-toxics-13-00126" ref-type="bibr">36</xref>]. Previous research shows that fluoride upregulates the BMP/Smad pathway [<xref rid="B37-toxics-13-00126" ref-type="bibr">37</xref>], stimulating BMP gene expression and increasing serum BMP levels [<xref rid="B38-toxics-13-00126" ref-type="bibr">38</xref>], which may enhance vascular calcification. Consistent with these findings, our study identified significant interactions between urinary fluoride concentration and the rs17563 polymorphism. We hypothesize that high fluoride exposure influences vascular calcification through the BMP pathway, providing new insights into the mechanisms underlying hypertension caused by fluoride exposure.</p><sec><title>Strengths and Limitation</title><p>It is noteworthy to mention that prior research has not documented any investigations on the correlation between gene polymorphism and fluoride exposure in relation to the susceptibility to hypertension. Consequently, the subject matter explored in this work possesses a distinctive and pioneering nature. The significance of the SNPs selected in this study on bone-related disorders has been demonstrated by thorough research in a wide range of individuals, so this postulates a mechanism: BMP2/4 gene mutations enhance hypertension risk with fluoride exposure. This work presents epidemiological evidence that vascular calcification, a link between BMP and hypertension, may play a regulatory function. Moreover, understanding the interplay between genetic polymorphisms and environmental exposures could lead to more personalized approaches in managing hypertension and other related conditions. However, this study has limitations. First, dietary and behavioral habits have a significant impact on hypertension, but the accuracy of the participants&#x02019; self-reported results is questionable and was therefore omitted from this study. Secondly, this study only included Han Chinese participants, and its findings may not be applicable to other ethnic groups. Finally, future research requires more varied and larger populations.</p></sec></sec><sec sec-type="conclusions" id="sec5-toxics-13-00126"><title>5. Conclusions</title><p>This study identified high fluoride exposure as a significant risk factor for hypertension. The rs1005464 (G &#x0003e; A) polymorphism of the BMP2 gene was associated with an increased risk of hypertension. Additionally, an interaction was discovered between the BMP2 rs1005464 polymorphism and the BMP4 rs17563 polymorphism in relation to hypertension. Furthermore, UF and the BMP4 rs17563 polymorphism have an interaction on hypertension.</p></sec></body><back><ack><title>Acknowledgments</title><p>We sincerely thank all study participants and research staff who participated in this work.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-toxics-13-00126"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at: <uri xlink:href="https://www.mdpi.com/article/10.3390/toxics13020126/s1">https://www.mdpi.com/article/10.3390/toxics13020126/s1</uri>, Table S1: Comparisons of the characteristics between the incluided and excluded participants by blood pressure levels.</p><supplementary-material id="toxics-13-00126-s001" position="float" content-type="local-data"><media xlink:href="toxics-13-00126-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, methodology, visualization, writing&#x02014;original draft, Y.G. (Yue Gao); formal analysis, resources, Q.W.; investigation, J.W.; data curation, software, writing&#x02014;review and editing X.W.; project administration, Y.L.; conceptualization, methodology, writing&#x02014;review and editing, supervision, Y.Y.; conceptualization, methodology, writing&#x02014;review and editing, supervision, funding acquisition, project administration, Y.G. (Yanhui Gao). All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>The study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the National Institute for Endemic Disease Control and Prevention, Chinese Center for Disease Control and Prevention (protocol code hrbmuecdc20210303, date of approval is 1 March 2021).</p></notes><notes><title>Informed Consent Statement</title><p>Informed consent was obtained from all subjects involved in the study.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The data that support the findings of this study are available from the corresponding author upon reasonable request.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-toxics-13-00126"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alkurdi</surname><given-names>S.S.A.</given-names></name>
<name><surname>Al-Juboori</surname><given-names>R.A.</given-names></name>
<name><surname>Bundschuh</surname><given-names>J.</given-names></name>
<name><surname>Hamawand</surname><given-names>I.</given-names></name>
</person-group><article-title>Bone Char as a Green Sorbent for Removing Health Threatening Fluoride from Drinking Water</article-title><source>Environ. Int.</source><year>2019</year><volume>127</volume><fpage>704</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1016/j.envint.2019.03.065</pub-id><pub-id pub-id-type="pmid">30999128</pub-id>
</element-citation></ref><ref id="B2-toxics-13-00126"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Daiwile</surname><given-names>A.P.</given-names></name>
<name><surname>Tarale</surname><given-names>P.</given-names></name>
<name><surname>Sivanesan</surname><given-names>S.</given-names></name>
<name><surname>Naoghare</surname><given-names>P.K.</given-names></name>
<name><surname>Bafana</surname><given-names>A.</given-names></name>
<name><surname>Parmar</surname><given-names>D.</given-names></name>
<name><surname>Kannan</surname><given-names>K.</given-names></name>
</person-group><article-title>Role of Fluoride Induced Epigenetic Alterations in the Development of Skeletal Fluorosis</article-title><source>Ecotoxicol. Env. Saf.</source><year>2019</year><volume>169</volume><fpage>410</fpage><lpage>417</lpage><pub-id pub-id-type="doi">10.1016/j.ecoenv.2018.11.035</pub-id><pub-id pub-id-type="pmid">30469026</pub-id>
</element-citation></ref><ref id="B3-toxics-13-00126"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wei</surname><given-names>W.</given-names></name>
<name><surname>Pang</surname><given-names>S.</given-names></name>
<name><surname>Sun</surname><given-names>D.</given-names></name>
</person-group><article-title>The pathogenesis of endemic fluorosis: Research progress in the last 5 years</article-title><source>J. Cell Mol. Med.</source><year>2019</year><volume>23</volume><fpage>2333</fpage><lpage>2342</lpage><pub-id pub-id-type="doi">10.1111/jcmm.14185</pub-id><pub-id pub-id-type="pmid">30784186</pub-id>
</element-citation></ref><ref id="B4-toxics-13-00126"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yuan</surname><given-names>L.</given-names></name>
<name><surname>Sun</surname><given-names>H.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Xing</surname><given-names>Z.</given-names></name>
<name><surname>Yin</surname><given-names>S.</given-names></name>
<name><surname>Xie</surname><given-names>F.</given-names></name>
<name><surname>Zhou</surname><given-names>J.</given-names></name>
<name><surname>Li</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>L.</given-names></name>
<name><surname>Huang</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Fluoride Exposure from Drinking Water Increases the Risk of Stroke: An Ecological Study in Changwu Town, China</article-title><source>Toxics</source><year>2024</year><volume>12</volume><elocation-id>679</elocation-id><pub-id pub-id-type="doi">10.3390/toxics12090679</pub-id><pub-id pub-id-type="pmid">39330607</pub-id>
</element-citation></ref><ref id="B5-toxics-13-00126"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Zhao</surname><given-names>Y.</given-names></name>
<name><surname>Tian</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>P.</given-names></name>
<name><surname>Xie</surname><given-names>J.</given-names></name>
<name><surname>Dong</surname><given-names>N.</given-names></name>
<name><surname>Feng</surname><given-names>J.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
<name><surname>Qiu</surname><given-names>Y.</given-names></name>
<etal/>
</person-group><article-title>Fluoride Exposure and Blood Pressure: A Systematic Review and Meta-Analys</article-title><source>Biol. Trace Elem. Res.</source><year>2021</year><volume>199</volume><fpage>925</fpage><lpage>934</lpage><pub-id pub-id-type="doi">10.1007/s12011-020-02232-6</pub-id><pub-id pub-id-type="pmid">32602052</pub-id>
</element-citation></ref><ref id="B6-toxics-13-00126"><label>6.</label><element-citation publication-type="gov"><article-title>Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease-PMC</article-title><comment>Available online: <ext-link xlink:href="https://pmc.ncbi.nlm.nih.gov/articles/PMC5765875/" ext-link-type="uri">https://pmc.ncbi.nlm.nih.gov/articles/PMC5765875/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-11-08">(accessed on 8 November 2024)</date-in-citation></element-citation></ref><ref id="B7-toxics-13-00126"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Krajewska-W&#x00142;odarczyk</surname><given-names>M.</given-names></name>
<name><surname>Stomp&#x000f3;r</surname><given-names>T.</given-names></name>
</person-group><article-title>Osteoporosis and vascular calcification in rheumatoid arthritis-the role of osteoprotegerin and sclerostin</article-title><source>Pol. Merkur. Lek.</source><year>2017</year><volume>43</volume><fpage>41</fpage><lpage>47</lpage></element-citation></ref><ref id="B8-toxics-13-00126"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Everett</surname><given-names>E.T.</given-names></name>
</person-group><article-title>Fluoride&#x02019;s Effects on the Formation of Teeth and Bones, and the Influence of Genetics</article-title><source>J. Dent. Res.</source><year>2011</year><volume>90</volume><fpage>552</fpage><lpage>560</lpage><pub-id pub-id-type="doi">10.1177/0022034510384626</pub-id><pub-id pub-id-type="pmid">20929720</pub-id>
</element-citation></ref><ref id="B9-toxics-13-00126"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pan</surname><given-names>L.</given-names></name>
<name><surname>Shi</surname><given-names>X.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Guo</surname><given-names>X.</given-names></name>
<name><surname>Zhao</surname><given-names>M.</given-names></name>
<name><surname>Cai</surname><given-names>R.</given-names></name>
<name><surname>Sun</surname><given-names>G.</given-names></name>
</person-group><article-title>Fluoride Promotes Osteoblastic Differentiation through Canonical Wnt/&#x003b2;-Catenin Signaling Pathway</article-title><source>Toxicol. Lett.</source><year>2014</year><volume>225</volume><fpage>34</fpage><lpage>42</lpage><pub-id pub-id-type="doi">10.1016/j.toxlet.2013.11.029</pub-id><pub-id pub-id-type="pmid">24300170</pub-id>
</element-citation></ref><ref id="B10-toxics-13-00126"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ma</surname><given-names>Y.</given-names></name>
<name><surname>Yao</surname><given-names>Y.</given-names></name>
<name><surname>Zhong</surname><given-names>N.</given-names></name>
<name><surname>Angwa</surname><given-names>L.M.</given-names></name>
<name><surname>Pei</surname><given-names>J.</given-names></name>
</person-group><article-title>The Dose-Time Effects of Fluoride on the Expression and DNA Methylation Level of the Promoter Region of BMP-2 and BMP-7 in Rats</article-title><source>Env. Toxicol. Pharmacol.</source><year>2020</year><volume>75</volume><fpage>103331</fpage><pub-id pub-id-type="doi">10.1016/j.etap.2020.103331</pub-id><pub-id pub-id-type="pmid">32004919</pub-id>
</element-citation></ref><ref id="B11-toxics-13-00126"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Cao</surname><given-names>F.</given-names></name>
<name><surname>Liu</surname><given-names>S.</given-names></name>
<name><surname>Mi</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>J.</given-names></name>
</person-group><article-title>BMP2/Smad Signaling Pathway Is Involved in the Inhibition Function of Fibroblast Growth Factor 21 on Vascular Calcification</article-title><source>Biochem. Biophys. Res. Commun.</source><year>2018</year><volume>503</volume><fpage>930</fpage><lpage>937</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.06.098</pub-id><pub-id pub-id-type="pmid">29932916</pub-id>
</element-citation></ref><ref id="B12-toxics-13-00126"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Zhao</surname><given-names>Q.</given-names></name>
<name><surname>Liu</surname><given-names>Y.</given-names></name>
<name><surname>Liu</surname><given-names>X.</given-names></name>
<name><surname>Chu</surname><given-names>Y.</given-names></name>
<name><surname>Yan</surname><given-names>H.</given-names></name>
<name><surname>Fan</surname><given-names>Y.</given-names></name>
<name><surname>Huo</surname><given-names>S.</given-names></name>
<name><surname>Wang</surname><given-names>L.</given-names></name>
<name><surname>Lou</surname><given-names>Q.</given-names></name>
<etal/>
</person-group><article-title>FRZB1 Rs2242070 Polymorphisms Is Associated with Brick Tea Type Skeletal Fluorosis in Kazakhs, but Not in Tibetans, China</article-title><source>Arch. Toxicol.</source><year>2018</year><volume>92</volume><fpage>2217</fpage><lpage>2225</lpage><pub-id pub-id-type="doi">10.1007/s00204-018-2217-9</pub-id><pub-id pub-id-type="pmid">29785637</pub-id>
</element-citation></ref><ref id="B13-toxics-13-00126"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Padmanabhan</surname><given-names>S.</given-names></name>
<name><surname>Dominiczak</surname><given-names>A.F.</given-names></name>
</person-group><article-title>Genomics of Hypertension: The Road to Precision Medicine</article-title><source>Nat. Rev. Cardiol.</source><year>2021</year><volume>18</volume><fpage>235</fpage><lpage>250</lpage><pub-id pub-id-type="doi">10.1038/s41569-020-00466-4</pub-id><pub-id pub-id-type="pmid">33219353</pub-id>
</element-citation></ref><ref id="B14-toxics-13-00126"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Piesanen</surname><given-names>J.V.I.</given-names></name>
<name><surname>Nikkari</surname><given-names>S.T.</given-names></name>
<name><surname>Kunnas</surname><given-names>T.A.</given-names></name>
</person-group><article-title>Genetic Variation in Bone Morphogenetic Proteins Family Members (BMPs 2 and 4) and Hypertension Risk in Middle-Aged Men: The TAMRISK Study</article-title><source>Medicine</source><year>2017</year><volume>96</volume><fpage>e9362</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000009362</pub-id><pub-id pub-id-type="pmid">29390526</pub-id>
</element-citation></ref><ref id="B15-toxics-13-00126"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>B.-F.</given-names></name>
</person-group><article-title>Predictive Values of Body Mass Index and Waist Circumference for Risk Factors of Certain Related Diseases in Chinese Adults: Study on Optimal Cut-off Points of Body Mass Index and Waist Circumference in Chinese Adults</article-title><source>Asia Pac. J. Clin. Nutr.</source><year>2002</year><volume>11</volume><fpage>S685</fpage><lpage>S693</lpage><pub-id pub-id-type="doi">10.1046/j.1440-6047.11.s8.9.x</pub-id></element-citation></ref><ref id="B16-toxics-13-00126"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Unger</surname><given-names>T.</given-names></name>
<name><surname>Borghi</surname><given-names>C.</given-names></name>
<name><surname>Charchar</surname><given-names>F.</given-names></name>
<name><surname>Khan</surname><given-names>N.A.</given-names></name>
<name><surname>Poulter</surname><given-names>N.R.</given-names></name>
<name><surname>Prabhakaran</surname><given-names>D.</given-names></name>
<name><surname>Schutte</surname><given-names>A.E.</given-names></name>
</person-group><article-title>2020 International Society of Hypertension Global Hypertension Practice Guidelines</article-title><source>J. Hypertens.</source><year>2020</year><volume>38</volume><fpage>982</fpage><lpage>1004</lpage><pub-id pub-id-type="doi">10.1097/HJH.0000000000002453</pub-id><pub-id pub-id-type="pmid">32371787</pub-id>
</element-citation></ref><ref id="B17-toxics-13-00126"><label>17.</label><element-citation publication-type="book"><std>WS/T 89-2015</std><source>Determination of Fluoride in Urine-Ion Selective Electrode Method</source><publisher-name>National Health and Family Planning Commission of the People&#x02019;s Republic of China</publisher-name><publisher-loc>Beijing, China</publisher-loc><year>2015</year></element-citation></ref><ref id="B18-toxics-13-00126"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gilbert</surname><given-names>J.W.</given-names></name>
</person-group><article-title>Fluorosis</article-title><source>J. Am. Dent. Assoc.</source><year>2002</year><volume>133</volume><fpage>544</fpage><pub-id pub-id-type="doi">10.14219/jada.archive.2002.0216</pub-id></element-citation></ref><ref id="B19-toxics-13-00126"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Melila</surname><given-names>M.</given-names></name>
<name><surname>Rajendran</surname><given-names>R.</given-names></name>
<name><surname>Lumo</surname><given-names>A.K.</given-names></name>
<name><surname>Arumugam</surname><given-names>G.</given-names></name>
<name><surname>Kpemissi</surname><given-names>M.</given-names></name>
<name><surname>Sadikou</surname><given-names>A.</given-names></name>
<name><surname>Lazar</surname><given-names>G.</given-names></name>
<name><surname>Amouzou</surname><given-names>K.</given-names></name>
</person-group><article-title>Cardiovascular Dysfunction and Oxidative Stress Following Human Contamination by Fluoride along with Environmental Xenobiotics (Cd &#x00026; Pb) in the Phosphate Treatment Area of Togo, West Africa</article-title><source>J. Trace Elem. Med. Biol.</source><year>2019</year><volume>56</volume><fpage>13</fpage><lpage>20</lpage><pub-id pub-id-type="doi">10.1016/j.jtemb.2019.07.002</pub-id><pub-id pub-id-type="pmid">31442949</pub-id>
</element-citation></ref><ref id="B20-toxics-13-00126"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bera</surname><given-names>I.</given-names></name>
<name><surname>Sabatini</surname><given-names>R.</given-names></name>
<name><surname>Auteri</surname><given-names>P.</given-names></name>
<name><surname>Flace</surname><given-names>P.</given-names></name>
<name><surname>Sisto</surname><given-names>G.</given-names></name>
<name><surname>Montagnani</surname><given-names>M.</given-names></name>
<name><surname>Potenza</surname><given-names>M.A.</given-names></name>
<name><surname>Marasciulo</surname><given-names>F.L.</given-names></name>
<name><surname>Carratu</surname><given-names>M.R.</given-names></name>
<name><surname>Coluccia</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Neurofunctional Effects of Developmental Sodium Fluoride Exposure in Rats</article-title><source>Eur. Rev. Med. Pharmacol. Sci.</source><year>2007</year><volume>11</volume><fpage>211</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">17876956</pub-id>
</element-citation></ref><ref id="B21-toxics-13-00126"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caruso</surname><given-names>F.S.</given-names></name>
<name><surname>Hodge</surname><given-names>H.C.</given-names></name>
</person-group><article-title>The Effect of Oral Doses of Sodium Fluoride on Blood Pressure in Dogs</article-title><source>J. Dent. Res.</source><year>1965</year><volume>44</volume><fpage>99</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.1177/00220345650440013801</pub-id><pub-id pub-id-type="pmid">14245504</pub-id>
</element-citation></ref><ref id="B22-toxics-13-00126"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chung</surname><given-names>M.-I.</given-names></name>
<name><surname>Bujnis</surname><given-names>M.</given-names></name>
<name><surname>Barkauskas</surname><given-names>C.E.</given-names></name>
<name><surname>Kobayashi</surname><given-names>Y.</given-names></name>
<name><surname>Hogan</surname><given-names>B.L.M.</given-names></name>
</person-group><article-title>Niche-Mediated BMP/SMAD Signaling Regulates Lung Alveolar Stem Cell Proliferation and Differentiation</article-title><source>Development</source><year>2018</year><volume>145</volume><fpage>dev163014</fpage><pub-id pub-id-type="doi">10.1242/dev.163014</pub-id><pub-id pub-id-type="pmid">29752282</pub-id>
</element-citation></ref><ref id="B23-toxics-13-00126"><label>23.</label><element-citation publication-type="webpage"><article-title>Bone Morphogenetic Protein (BMP)-2 Induces Apoptosis in Human Myeloma Cells: Leukemia &#x00026; Lymphoma: Volume 43, No 3</article-title><comment>Available online: <ext-link xlink:href="https://www.tandfonline.com/doi/abs/10.1080/10428190290012182" ext-link-type="uri">https://www.tandfonline.com/doi/abs/10.1080/10428190290012182</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-12-08">(accessed on 8 December 2024)</date-in-citation></element-citation></ref><ref id="B24-toxics-13-00126"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Salazar</surname><given-names>V.S.</given-names></name>
<name><surname>Gamer</surname><given-names>L.W.</given-names></name>
<name><surname>Rosen</surname><given-names>V.</given-names></name>
</person-group><article-title>BMP Signalling in Skeletal Development, Disease and Repair</article-title><source>Nat. Rev. Endocrinol.</source><year>2016</year><volume>12</volume><fpage>203</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1038/nrendo.2016.12</pub-id><pub-id pub-id-type="pmid">26893264</pub-id>
</element-citation></ref><ref id="B25-toxics-13-00126"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cabiati</surname><given-names>M.</given-names></name>
<name><surname>Vozzi</surname><given-names>F.</given-names></name>
<name><surname>Ceccherini</surname><given-names>E.</given-names></name>
<name><surname>Guiducci</surname><given-names>L.</given-names></name>
<name><surname>Persiani</surname><given-names>E.</given-names></name>
<name><surname>Gisone</surname><given-names>I.</given-names></name>
<name><surname>Sgalippa</surname><given-names>A.</given-names></name>
<name><surname>Cecchettini</surname><given-names>A.</given-names></name>
<name><surname>Del Ry</surname><given-names>S.</given-names></name>
</person-group><article-title>Exploring Bone Morphogenetic Protein-2 and -4 mRNA Expression and Their Receptor Assessment in a Dynamic In Vitro Model of Vascular Calcification</article-title><source>Cells</source><year>2024</year><volume>13</volume><elocation-id>2091</elocation-id><pub-id pub-id-type="doi">10.3390/cells13242091</pub-id><pub-id pub-id-type="pmid">39768183</pub-id>
</element-citation></ref><ref id="B26-toxics-13-00126"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shaul</surname><given-names>O.</given-names></name>
</person-group><article-title>How Introns Enhance Gene Expression</article-title><source>Int. J. Biochem. Cell Biol.</source><year>2017</year><volume>91</volume><fpage>145</fpage><lpage>155</lpage><pub-id pub-id-type="doi">10.1016/j.biocel.2017.06.016</pub-id><pub-id pub-id-type="pmid">28673892</pub-id>
</element-citation></ref><ref id="B27-toxics-13-00126"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ara&#x000fa;jo</surname><given-names>T.K.</given-names></name>
<name><surname>Simioni</surname><given-names>M.</given-names></name>
<name><surname>F&#x000e9;lix</surname><given-names>T.M.</given-names></name>
<name><surname>de Souza</surname><given-names>L.T.</given-names></name>
<name><surname>Fontes</surname><given-names>M.&#x000cd;.B.</given-names></name>
<name><surname>Monlle&#x000f3;</surname><given-names>I.L.</given-names></name>
<name><surname>Souza</surname><given-names>J.</given-names></name>
<name><surname>Fett-Conte</surname><given-names>A.C.</given-names></name>
<name><surname>Secolin</surname><given-names>R.</given-names></name>
<name><surname>Lopes-Cendes</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Preliminary Analysis of the Nonsynonymous Polymorphism Rs17563 in BMP4 Gene in Brazilian Population Suggests Protection for Nonsyndromic Cleft Lip and Palate</article-title><source>Plast. Surg. Int.</source><year>2012</year><volume>2012</volume><fpage>247104</fpage><pub-id pub-id-type="doi">10.1155/2012/247104</pub-id><pub-id pub-id-type="pmid">23227324</pub-id>
</element-citation></ref><ref id="B28-toxics-13-00126"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hansdah</surname><given-names>K.</given-names></name>
<name><surname>Singh</surname><given-names>N.</given-names></name>
<name><surname>Bouzid</surname><given-names>A.</given-names></name>
<name><surname>Priyadarshi</surname><given-names>S.</given-names></name>
<name><surname>Ray</surname><given-names>C.S.</given-names></name>
<name><surname>Desai</surname><given-names>A.</given-names></name>
<name><surname>Panda</surname><given-names>K.C.</given-names></name>
<name><surname>Choudhury</surname><given-names>J.C.</given-names></name>
<name><surname>Biswal</surname><given-names>N.C.</given-names></name>
<name><surname>Tekari</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title>Evaluation of the Genetic Association and mRNA Expression of the COL1A1, BMP2, and BMP4 Genes in the Development of Otosclerosis</article-title><source>Genet. Test. Mol. Biomark.</source><year>2020</year><volume>24</volume><fpage>343</fpage><lpage>351</lpage><pub-id pub-id-type="doi">10.1089/gtmb.2019.0235</pub-id></element-citation></ref><ref id="B29-toxics-13-00126"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>K&#x000fc;chler</surname><given-names>E.C.</given-names></name>
<name><surname>Hannegraf</surname><given-names>N.D.</given-names></name>
<name><surname>Lara</surname><given-names>R.M.</given-names></name>
<name><surname>Reis</surname><given-names>C.L.B.</given-names></name>
<name><surname>de Oliveira</surname><given-names>D.S.B.</given-names></name>
<name><surname>Mazzi-Chaves</surname><given-names>J.F.</given-names></name>
<name><surname>Ribeiro Andrades</surname><given-names>K.M.</given-names></name>
<name><surname>de Lima</surname><given-names>L.F.</given-names></name>
<name><surname>Salles</surname><given-names>A.G.</given-names></name>
<name><surname>Antunes</surname><given-names>L.A.A.</given-names></name>
<etal/>
</person-group><article-title>Investigation of Genetic Polymorphisms in BMP2, BMP4, SMAD6, and RUNX2 and Persistent Apical Periodontitis</article-title><source>J. Endod.</source><year>2021</year><volume>47</volume><fpage>278</fpage><lpage>285</lpage><pub-id pub-id-type="doi">10.1016/j.joen.2020.11.014</pub-id><pub-id pub-id-type="pmid">33245975</pub-id>
</element-citation></ref><ref id="B30-toxics-13-00126"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bai</surname><given-names>H.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>Arzigian</surname><given-names>M.</given-names></name>
<name><surname>Wojchowski</surname><given-names>D.M.</given-names></name>
<name><surname>Wu</surname><given-names>W.-S.</given-names></name>
<name><surname>Wang</surname><given-names>Z.Z.</given-names></name>
</person-group><article-title>BMP4 Regulates Vascular Progenitor Development in Human Embryonic Stem Cells through a Smad-Dependent Pathway</article-title><source>J. Cell Biochem.</source><year>2010</year><volume>109</volume><fpage>363</fpage><lpage>374</lpage><pub-id pub-id-type="doi">10.1002/jcb.22410</pub-id><pub-id pub-id-type="pmid">19950207</pub-id>
</element-citation></ref><ref id="B31-toxics-13-00126"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lagna</surname><given-names>G.</given-names></name>
<name><surname>Nguyen</surname><given-names>P.H.</given-names></name>
<name><surname>Ni</surname><given-names>W.</given-names></name>
<name><surname>Hata</surname><given-names>A.</given-names></name>
</person-group><article-title>BMP-Dependent Activation of Caspase-9 and Caspase-8 Mediates Apoptosis in Pulmonary Artery Smooth Muscle Cells</article-title><source>Am. J. Physiol. Lung Cell Mol. Physiol.</source><year>2006</year><volume>291</volume><fpage>L1059</fpage><lpage>L1067</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00180.2006</pub-id><pub-id pub-id-type="pmid">17030903</pub-id>
</element-citation></ref><ref id="B32-toxics-13-00126"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morrell</surname><given-names>N.W.</given-names></name>
<name><surname>Yang</surname><given-names>X.</given-names></name>
<name><surname>Upton</surname><given-names>P.D.</given-names></name>
<name><surname>Jourdan</surname><given-names>K.B.</given-names></name>
<name><surname>Morgan</surname><given-names>N.</given-names></name>
<name><surname>Sheares</surname><given-names>K.K.</given-names></name>
<name><surname>Trembath</surname><given-names>R.C.</given-names></name>
</person-group><article-title>Altered Growth Responses of Pulmonary Artery Smooth Muscle Cells from Patients with Primary Pulmonary Hypertension to Transforming Growth Factor-Beta(1) and Bone Morphogenetic Proteins</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>790</fpage><lpage>795</lpage><pub-id pub-id-type="doi">10.1161/hc3201.094152</pub-id><pub-id pub-id-type="pmid">11502704</pub-id>
</element-citation></ref><ref id="B33-toxics-13-00126"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gu</surname><given-names>G.L.</given-names></name>
<name><surname>Yang</surname><given-names>Q.Y.</given-names></name>
<name><surname>Zeng</surname><given-names>R.L.</given-names></name>
<name><surname>Xu</surname><given-names>X.L.</given-names></name>
</person-group><article-title>The Association between BMP4 Gene Polymorphism and Its Serum Level with the Incidence of LVH in Hypertensive Patients</article-title><source>J. Transl. Med.</source><year>2015</year><volume>13</volume><fpage>14</fpage><pub-id pub-id-type="doi">10.1186/s12967-014-0368-x</pub-id><pub-id pub-id-type="pmid">25591903</pub-id>
</element-citation></ref><ref id="B34-toxics-13-00126"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panizo</surname><given-names>S.</given-names></name>
<name><surname>Cardus</surname><given-names>A.</given-names></name>
<name><surname>Encinas</surname><given-names>M.</given-names></name>
<name><surname>Parisi</surname><given-names>E.</given-names></name>
<name><surname>Valcheva</surname><given-names>P.</given-names></name>
<name><surname>L&#x000f3;pez-Ongil</surname><given-names>S.</given-names></name>
<name><surname>Coll</surname><given-names>B.</given-names></name>
<name><surname>Fernandez</surname><given-names>E.</given-names></name>
<name><surname>Valdivielso</surname><given-names>J.M.</given-names></name>
</person-group><article-title>RANKL Increases Vascular Smooth Muscle Cell Calcification through a RANK-BMP4-Dependent Pathway</article-title><source>Circ. Res.</source><year>2009</year><volume>104</volume><fpage>1041</fpage><lpage>1048</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.108.189001</pub-id><pub-id pub-id-type="pmid">19325147</pub-id>
</element-citation></ref><ref id="B35-toxics-13-00126"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>W.T.</given-names></name>
<name><surname>Tian</surname><given-names>X.Y.</given-names></name>
<name><surname>Chen</surname><given-names>Y.</given-names></name>
<name><surname>Leung</surname><given-names>F.P.</given-names></name>
<name><surname>Liu</surname><given-names>L.</given-names></name>
<name><surname>Lee</surname><given-names>H.K.</given-names></name>
<name><surname>Ng</surname><given-names>C.F.</given-names></name>
<name><surname>Xu</surname><given-names>A.</given-names></name>
<name><surname>Yao</surname><given-names>X.</given-names></name>
<name><surname>Vanhoutte</surname><given-names>P.M.</given-names></name>
<etal/>
</person-group><article-title>Bone Morphogenic Protein-4 Impairs Endothelial Function through Oxidative Stress-Dependent Cyclooxygenase-2 Upregulation: Implications on Hypertension</article-title><source>Circ. Res.</source><year>2010</year><volume>107</volume><fpage>984</fpage><lpage>991</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.110.222794</pub-id><pub-id pub-id-type="pmid">20724703</pub-id>
</element-citation></ref><ref id="B36-toxics-13-00126"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Miriyala</surname><given-names>S.</given-names></name>
<name><surname>Gongora Nieto</surname><given-names>M.C.</given-names></name>
<name><surname>Mingone</surname><given-names>C.</given-names></name>
<name><surname>Smith</surname><given-names>D.</given-names></name>
<name><surname>Dikalov</surname><given-names>S.</given-names></name>
<name><surname>Harrison</surname><given-names>D.G.</given-names></name>
<name><surname>Jo</surname><given-names>H.</given-names></name>
</person-group><article-title>Bone Morphogenic Protein-4 Induces Hypertension in Mice: Role of Noggin, Vascular NADPH Oxidases, and Impaired Vasorelaxation</article-title><source>Circulation</source><year>2006</year><volume>113</volume><fpage>2818</fpage><lpage>2825</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.106.611822</pub-id><pub-id pub-id-type="pmid">16769910</pub-id>
</element-citation></ref><ref id="B37-toxics-13-00126"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jiang</surname><given-names>Y.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>H.</given-names></name>
<name><surname>Darko</surname><given-names>G.M.</given-names></name>
<name><surname>Sun</surname><given-names>D.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
</person-group><article-title>Identification of miR-200c-3p as a Major Regulator of SaoS2 Cells Activation Induced by Fluoride</article-title><source>Chemosphere</source><year>2018</year><volume>199</volume><fpage>694</fpage><lpage>701</lpage><pub-id pub-id-type="doi">10.1016/j.chemosphere.2018.01.095</pub-id><pub-id pub-id-type="pmid">29471239</pub-id>
</element-citation></ref><ref id="B38-toxics-13-00126"><label>38.</label><element-citation publication-type="webpage"><article-title>Influence of Brick-Tea Fluoride Exposure on Levels of Bone Morphogenetic Protein 2 Expression in Human Serum|Semantic Scholar</article-title><comment>Available online: <ext-link xlink:href="https://www.semanticscholar.org/paper/Influence-of-brick-tea-fluoride-exposure-on-levels-Fan-Sun/43f77fe16a657f3202fccff62f9b1e9cafe99775" ext-link-type="uri">https://www.semanticscholar.org/paper/Influence-of-brick-tea-fluoride-exposure-on-levels-Fan-Sun/43f77fe16a657f3202fccff62f9b1e9cafe99775</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-03-27">(accessed on 27 March 2024)</date-in-citation></element-citation></ref></ref-list></back><floats-group><table-wrap position="float" id="toxics-13-00126-t001"><object-id pub-id-type="pii">toxics-13-00126-t001_Table 1</object-id><label>Table 1</label><caption><p>Population characteristics of hypertension case group and control group.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Case</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>&#x000a0;<sup>c</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Test</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI) <sup>d</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">63(54&#x02013;67)</td><td align="center" valign="middle" rowspan="1" colspan="1">55(46&#x02013;64)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Z = &#x02212;6.852</td><td align="center" valign="middle" rowspan="1" colspan="1">1.052(1.036&#x02013;1.068)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">26.421(23.980&#x02013;28.611)</td><td align="center" valign="middle" rowspan="1" colspan="1">24.614(22.621&#x02013;26.676)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Z = &#x02212;6.154</td><td align="center" valign="middle" rowspan="1" colspan="1">1.129(1.080&#x02013;1.181)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urinary fluoride(mg/L) <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">1.364(0.972&#x02013;1.917)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.147(0.825&#x02013;1.726)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">Z = &#x02212;3.665</td><td align="center" valign="middle" rowspan="1" colspan="1">1.207(1.006&#x02013;1.499)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">122(33.15%)</td><td align="center" valign="middle" rowspan="1" colspan="1">116(32.49%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">246(66.85%)</td><td align="center" valign="middle" rowspan="1" colspan="1">241(67.51%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.850</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c7;<sup>2</sup> = 0.036</td><td align="center" valign="middle" rowspan="1" colspan="1">1.012(0.649&#x02013;1.577)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cigarette smoking <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">290(78.80%)</td><td align="center" valign="middle" rowspan="1" colspan="1">295(82.63%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">78(21.20%)</td><td align="center" valign="middle" rowspan="1" colspan="1">62(17.37%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.192</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x003c7;<sup>2</sup> = 1.705</td><td align="center" valign="middle" rowspan="1" colspan="1">1.578(0.966&#x02013;2.577)</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alcohol drinking <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">304(82.60%)</td><td align="center" valign="middle" rowspan="1" colspan="1">288(80.67%)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64(17.40%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">69(19.33%)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.501</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003c7;<sup>2</sup> = 0.454</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.800(0.483&#x02013;1.326)</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> Age, BMI, and urinary fluoride concentrations did not follow a normal distribution and are reported as medians with interquartile ranges (25%, 75%). <sup>b</sup> Number (percentage/proportion) for categorical variables. <sup>c</sup> the Mann&#x02013;Whitney U test was applied to compare the difference of continuous variables, and chi-squared test was used to compare the difference of categorical variables. <sup>d</sup> Crude model.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t002"><object-id pub-id-type="pii">toxics-13-00126-t002_Table 2</object-id><label>Table 2</label><caption><p>Association of urinary fluoride (mg/L) with hypertension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">UF Levels (mg/L, Median[Range])</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">N(EH/Non-EH)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model1</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model2</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95% CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Q1(0.70[&#x0003c;0.87])</td><td align="center" valign="middle" rowspan="1" colspan="1">227(92/135)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Q2(1.08[0.88&#x02013;1.25])</td><td align="center" valign="middle" rowspan="1" colspan="1">227(104/123)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.352(0.892&#x02013;2.049)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.156</td><td align="center" valign="middle" rowspan="1" colspan="1">1.211(0.779&#x02013;1.881)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.395</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Q3(1.48[1.26&#x02013;1.80])</td><td align="center" valign="middle" rowspan="1" colspan="1">228(125/103)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.063(1.358&#x02013;3.134)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.513(1.178&#x02013;2.850)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.007</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Q4(2.39[&#x02265;1.81])</td><td align="center" valign="middle" rowspan="1" colspan="1">227(133/94)</td><td align="center" valign="middle" rowspan="1" colspan="1">2.017(1.328&#x02013;3.063)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.647(1.056&#x02013;2.570)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.028</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Trend test</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.496(1.182&#x02013;1.894)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.343(1.045&#x02013;1.726)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.021</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increase per 1mg/L</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.307(1.098&#x02013;1.556)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.003</bold>
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.207(1.006&#x02013;1.449)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<bold>0.043</bold>
</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. Model 1: crude model. Model 2: adjusted for age, gender, BMI, cigarette smoking, and alcohol drinking. Trend test: median UF for each quantile was included as a continuous variable.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t003"><object-id pub-id-type="pii">toxics-13-00126-t003_Table 3</object-id><label>Table 3</label><caption><p>Five genetic models&#x02019; analysis of the association between the SNPs of BMP2/BMP4 and hypertension in all subjects.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">SNP</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Genetic Model</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Genotype</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Case N(%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control N(%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>&#x000a0;<sup>a</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">AIC</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">BIC</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">rs1005464</td><td align="center" valign="middle" rowspan="1" colspan="1">Codominant</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">158(42.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">127(35.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.044</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">931.8</td><td align="center" valign="middle" rowspan="1" colspan="1">973.1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG</td><td align="center" valign="middle" rowspan="1" colspan="1">165(44.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">186(52.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.65(0.47&#x02013;0.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">45(12.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">44(12.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.78(0.47&#x02212;1.29)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Dominant</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">158(42.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">127(35.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.016</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">930.3</td><td align="center" valign="middle" rowspan="1" colspan="1">967</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">210(57.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">230(64.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.68(0.49&#x02013;0.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Recessive</td><td align="center" valign="middle" rowspan="1" colspan="1">GG + AG</td><td align="center" valign="middle" rowspan="1" colspan="1">323(87.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">313(87.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97</td><td align="center" valign="middle" rowspan="1" colspan="1">936.1</td><td align="center" valign="middle" rowspan="1" colspan="1">972.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">45(12.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">44(12.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99(0.62&#x02212;1.58)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Overdominant</td><td align="center" valign="middle" rowspan="1" colspan="1">GG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">203(55.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">171(47.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.021</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">930.7</td><td align="center" valign="middle" rowspan="1" colspan="1">967.4</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG</td><td align="center" valign="middle" rowspan="1" colspan="1">165(44.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">186(52.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.69(0.51&#x02013;0.95)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Log-additive</td><td align="center" valign="middle" rowspan="1" colspan="1">---</td><td align="center" valign="middle" rowspan="1" colspan="1">---</td><td align="center" valign="middle" rowspan="1" colspan="1">---</td><td align="center" valign="middle" rowspan="1" colspan="1">0.81(0.64&#x02212;1.02)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.076</td><td align="center" valign="middle" rowspan="1" colspan="1">932.9</td><td align="center" valign="middle" rowspan="1" colspan="1">969.6</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">rs17563</td><td align="center" valign="middle" rowspan="1" colspan="1">Codominant</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">182(49.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">184(51.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.27</td><td align="center" valign="middle" rowspan="1" colspan="1">935.5</td><td align="center" valign="middle" rowspan="1" colspan="1">976.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG</td><td align="center" valign="middle" rowspan="1" colspan="1">151(41)</td><td align="center" valign="middle" rowspan="1" colspan="1">148(41.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.07(0.77&#x02212;1.48)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">35(9.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">25(7.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.61(0.90&#x02212;2.89)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Dominant</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">182(49.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">184(51.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.38</td><td align="center" valign="middle" rowspan="1" colspan="1">935.3</td><td align="center" valign="middle" rowspan="1" colspan="1">972</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">186(50.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">173(48.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.15(0.84&#x02212;1.57)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Recessive</td><td align="center" valign="middle" rowspan="1" colspan="1">AA + AG</td><td align="center" valign="middle" rowspan="1" colspan="1">333(90.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">332(93.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.12</td><td align="center" valign="middle" rowspan="1" colspan="1">933.6</td><td align="center" valign="middle" rowspan="1" colspan="1">970.3</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">35(9.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">25(7.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.56(0.89&#x02212;2.75)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Overdominant</td><td align="center" valign="middle" rowspan="1" colspan="1">AA + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">217(59.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">209(58.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99</td><td align="center" valign="middle" rowspan="1" colspan="1">936.1</td><td align="center" valign="middle" rowspan="1" colspan="1">972.7</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG</td><td align="center" valign="middle" rowspan="1" colspan="1">151(41.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">148(41.5)</td><td align="center" valign="middle" rowspan="1" colspan="1">1.00(0.73&#x02212;1.37)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Log-additive</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">---</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">---</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">---</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.18(0.93&#x02212;1.50)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.18</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">934.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">970.9</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> Adjusted for age (continuous), gender, urinary fluoride (continuous), BMI (continuous), cigarette smoking, and alcohol drinking.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t004"><object-id pub-id-type="pii">toxics-13-00126-t004_Table 4</object-id><label>Table 4</label><caption><p>Distribution of hypertension prevalence in the GG genotype group vs. the AG + AA genotype group at the rs1005464 of BMP2.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Variant</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control(N)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Case(N)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">&#x003c7;<sup>2</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>&#x000a0;<sup>a</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Total</td><td align="center" valign="middle" rowspan="1" colspan="1">357</td><td align="center" valign="middle" rowspan="1" colspan="1">368</td><td align="center" valign="middle" rowspan="1" colspan="1">4.115</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.043</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age &#x0003c; 60</td><td align="center" valign="middle" rowspan="1" colspan="1">223</td><td align="center" valign="middle" rowspan="1" colspan="1">155</td><td align="center" valign="middle" rowspan="1" colspan="1">4.152</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.042</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age &#x02265; 60</td><td align="center" valign="middle" rowspan="1" colspan="1">134</td><td align="center" valign="middle" rowspan="1" colspan="1">213</td><td align="center" valign="middle" rowspan="1" colspan="1">1.193</td><td align="center" valign="middle" rowspan="1" colspan="1">0.275</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">116</td><td align="center" valign="middle" rowspan="1" colspan="1">122</td><td align="center" valign="middle" rowspan="1" colspan="1">1.576</td><td align="center" valign="middle" rowspan="1" colspan="1">0.209</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">241</td><td align="center" valign="middle" rowspan="1" colspan="1">246</td><td align="center" valign="middle" rowspan="1" colspan="1">2.533</td><td align="center" valign="middle" rowspan="1" colspan="1">0.112</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urinary fluoride &#x02264; 1.6 mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">256</td><td align="center" valign="middle" rowspan="1" colspan="1">235</td><td align="center" valign="middle" rowspan="1" colspan="1">2.396</td><td align="center" valign="middle" rowspan="1" colspan="1">0.122</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urinary fluoride &#x0003e; 1.6 mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">101</td><td align="center" valign="middle" rowspan="1" colspan="1">133</td><td align="center" valign="middle" rowspan="1" colspan="1">1.466</td><td align="center" valign="middle" rowspan="1" colspan="1">0.226</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI &#x0003c; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">152</td><td align="center" valign="middle" rowspan="1" colspan="1">92</td><td align="center" valign="middle" rowspan="1" colspan="1">1.687</td><td align="center" valign="middle" rowspan="1" colspan="1">0.194</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI &#x02265; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">205</td><td align="center" valign="middle" rowspan="1" colspan="1">276</td><td align="center" valign="middle" rowspan="1" colspan="1">2.606</td><td align="center" valign="middle" rowspan="1" colspan="1">0.106</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cigarette Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">62</td><td align="center" valign="middle" rowspan="1" colspan="1">78</td><td align="center" valign="middle" rowspan="1" colspan="1">2.159</td><td align="center" valign="middle" rowspan="1" colspan="1">0.142</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Non-Cigarette Smoking</td><td align="center" valign="middle" rowspan="1" colspan="1">295</td><td align="center" valign="middle" rowspan="1" colspan="1">290</td><td align="center" valign="middle" rowspan="1" colspan="1">2.316</td><td align="center" valign="middle" rowspan="1" colspan="1">0.128</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alcohol Drinking</td><td align="center" valign="middle" rowspan="1" colspan="1">69</td><td align="center" valign="middle" rowspan="1" colspan="1">64</td><td align="center" valign="middle" rowspan="1" colspan="1">9.179</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.002</bold>
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Non-Alcohol Drinking</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">288</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">304</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.653</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.419</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> Adjusted for age (continuous), gender, urinary fluoride (continuous), BMI (continuous), cigarette smoking, and alcohol drinking.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t005"><object-id pub-id-type="pii">toxics-13-00126-t005_Table 5</object-id><label>Table 5</label><caption><p>Association of BMP2 rs1005464 with hypertension risk stratified by potential risk factor.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">rs1005464</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Control N (%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Case N(%)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>&#x000a0;<sup>g</sup></th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic toggle="yes">p</italic>&#x000a0;<sup>h</sup></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age <sup>a</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age &#x0003c; 60</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">140(62.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">75(48.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">83(37.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">80(51.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.582(0.376&#x02212;0.900)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.031</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.015</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Age &#x02265; 60</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">44(32.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">83(39.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">90(67.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">130(61.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.808(0.500&#x02013;1.305)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.249</td><td align="center" valign="middle" rowspan="1" colspan="1">0.383</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gender <sup>b</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Male</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">43(37.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">55(45.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">73(62.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">67(54.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.704(0.402&#x02013;1.233)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.210</td><td align="center" valign="middle" rowspan="1" colspan="1">0.220</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Female</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">84(34.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">103(41.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">157(65.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">143(58.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.667(0.448&#x02212;0.991)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.112</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.045</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Urinary fluoride <sup>c</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">UF &#x02264; 1.6 mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">89(34.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">98(41.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">167(65.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">137(58.3)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.690(0.467&#x02013;1.021)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.122</td><td align="center" valign="middle" rowspan="1" colspan="1">0.063</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">UF &#x0003e; 1.6 mg/L</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">38(37.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">60(45.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">63(62.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">73(54.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.625(0.349&#x02013;1.120)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.227</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Body mass index (kgm<sup>2</sup>) <sup>d</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI &#x0003c; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">55(36.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">41(44.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">97(63.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">51(55.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.641(0.365&#x02013;1.124)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.195</td><td align="center" valign="middle" rowspan="1" colspan="1">0.121</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">BMI &#x02265; 24</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">72(35.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">117(42.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">133(64.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">159(57.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.684(0.460&#x02013;1.017)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.107</td><td align="center" valign="middle" rowspan="1" colspan="1">0.061</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Cigarette Smoking <sup>e</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">21(33.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">36(46.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">41(66.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">42(53.8)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.497(0.234&#x02013;1.055)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.530</td><td align="center" valign="middle" rowspan="1" colspan="1">0.069</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">106(35.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">122(42.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">189(64.1)</td><td align="center" valign="middle" rowspan="1" colspan="1">168(57.9)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.719(0.502&#x02013;1.029)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.150</td><td align="center" valign="middle" rowspan="1" colspan="1">0.071</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alcohol Drinking <sup>f</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Yes</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">17(24.6)</td><td align="center" valign="middle" rowspan="1" colspan="1">32(50.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">52(75.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">32(50.0)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.296(0.134&#x02212;0.655)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.003</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">No</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">110(38.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">126(41.4)</td><td align="center" valign="middle" rowspan="1" colspan="1">1(Ref)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">178(61.8)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">178(58.6)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.815(0.570&#x02013;1.165)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.399</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.262</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> Adjusted for gender, urinary fluoride (continuous), BMI (continuous), cigarette smoking, and alcohol drinking. <sup>b</sup> Adjusted for age (continuous), urinary fluoride (continuous), BMI (continuous), cigarette smoking, and alcohol drinking. <sup>c</sup> Adjusted for age (continuous), gender, BMI (continuous), cigarette smoking, and alcohol drinking. <sup>d</sup> Adjusted for age (continuous), gender, urinary fluoride (continuous), cigarette smoking, and alcohol drinking. <sup>e</sup> Adjusted for age (continuous), gender, urinary fluoride (continuous), BMI (continuous), and alcohol drinking. <sup>f</sup> Adjusted for age (continuous), gender, urinary fluoride (continuous), BMI (continuous), and cigarette smoking. <sup>g</sup> Crude model. <sup>h</sup> Adjust model.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t006"><object-id pub-id-type="pii">toxics-13-00126-t006_Table 6</object-id><label>Table 6</label><caption><p>The interaction effect of rs1005464 and rs17563 on EH.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">rs1005464</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">rs17563</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Control<break/>(N)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Case<break/>(N)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 1 <sup>a</sup></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 2 <sup>b</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p<sub>-interaction 1</sub></italic>&#x000a0;<sup>a</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p<sub>-interaction 2</sub></italic>&#x000a0;<sup>b</sup></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">110</td><td align="center" valign="middle" rowspan="1" colspan="1">109</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">74</td><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1">0.99(0.66&#x02013;1.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.983</td><td align="center" valign="middle" rowspan="1" colspan="1">0.97(0.62&#x02013;1.51)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.880</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">120</td><td align="center" valign="middle" rowspan="1" colspan="1">101</td><td align="center" valign="middle" rowspan="1" colspan="1">0.85(0.58&#x02013;1.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.393</td><td align="center" valign="middle" rowspan="1" colspan="1">0.84(0.56&#x02013;1.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.376</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">53</td><td align="center" valign="middle" rowspan="1" colspan="1">85</td><td align="center" valign="middle" rowspan="1" colspan="1">1.62(1.05&#x02013;2.50)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.029</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.99(1.25&#x02013;3.17)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.004</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.035</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">RERI</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.77(0.07&#x02013;1.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.13(0.33&#x02013;2.16)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15(0.01&#x02013;1.99)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.11(0.01&#x02013;1.74)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> Crude model. <sup>b</sup> Adjusted for age, gender, UF, BMI, cigarette smoking, and alcohol drinking.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t007"><object-id pub-id-type="pii">toxics-13-00126-t007_Table 7</object-id><label>Table 7</label><caption><p>The interaction effect of UF and BMP4 rs17563 SNP on hypertension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">UF <sup>a</sup> (mg/L)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">rs17563<break/>Genotype</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Control<break/>(N)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Case<break/>(N)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 1 <sup>b</sup></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 2 <sup>c</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p<sub>-interaction 1</sub></italic>&#x000a0;<sup>b</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">
<italic toggle="yes">p<sub>-interaction 2</sub>
</italic>
<sup>c</sup>
</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">125</td><td align="center" valign="middle" rowspan="1" colspan="1">127</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">130</td><td align="center" valign="middle" rowspan="1" colspan="1">108</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23(0.86&#x02013;1.76)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.248</td><td align="center" valign="middle" rowspan="1" colspan="1">1.23(0.76&#x02013;1.97)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.398</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AA</td><td align="center" valign="middle" rowspan="1" colspan="1">59</td><td align="center" valign="middle" rowspan="1" colspan="1">55</td><td align="center" valign="middle" rowspan="1" colspan="1">1.13(0.72&#x02013;1.77)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.602</td><td align="center" valign="middle" rowspan="1" colspan="1">1.06(0.65&#x02013;1.7)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.836</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + GG</td><td align="center" valign="middle" rowspan="1" colspan="1">43</td><td align="center" valign="middle" rowspan="1" colspan="1">78</td><td align="center" valign="middle" rowspan="1" colspan="1">2.25(1.43&#x02013;3.55)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>&#x0003c;0.001</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">2.21(1.27&#x02013;3.86)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.005</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.005</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.006</bold>
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RERI</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.35(&#x02212;2.51&#x02013;0.2)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">&#x02212;1.38(&#x02212;2.73&#x02013;0.03)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.09(0&#x02013;3.26)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.04(0&#x02013;168.11)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> UF included as a continuous variable. <sup>b</sup> Crude model. <sup>c</sup> Adjusted for gender, age, BMI, cigarette smoking, and alcohol drinking.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="toxics-13-00126-t008"><object-id pub-id-type="pii">toxics-13-00126-t008_Table 8</object-id><label>Table 8</label><caption><p>The interaction effect of UF and BMP2 rs1005464 SNP on hypertension.</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">UF <sup>a</sup><break/>(mg/L)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">rs1005464<break/>Genotype</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Control<break/>(N)</th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Case<break/>(N)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 1 <sup>b</sup></th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Model 2 <sup>c</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p<sub>-interaction 1</sub></italic>&#x000a0;<sup>b</sup></th><th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1"><italic toggle="yes">p<sub>-interaction 2</sub></italic>&#x000a0;<sup>c</sup></th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">OR(95%CI)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>
</th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">167</td><td align="center" valign="middle" rowspan="1" colspan="1">137</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">Ref.</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x02264;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">89</td><td align="center" valign="middle" rowspan="1" colspan="1">98</td><td align="center" valign="middle" rowspan="1" colspan="1">1.34(0.93&#x02013;1.93)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.114</td><td align="center" valign="middle" rowspan="1" colspan="1">1.43(0.97&#x02013;2.11)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.072</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">GG</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">60</td><td align="center" valign="middle" rowspan="1" colspan="1">1.92(1.21&#x02013;3.06)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.006</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">1.95(1.19&#x02013;3.21)</td><td align="center" valign="middle" rowspan="1" colspan="1">
<bold>0.008</bold>
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">&#x0003e;1.6</td><td align="center" valign="middle" rowspan="1" colspan="1">AG + AA</td><td align="center" valign="middle" rowspan="1" colspan="1">63</td><td align="center" valign="middle" rowspan="1" colspan="1">73</td><td align="center" valign="middle" rowspan="1" colspan="1">1.41(0.94&#x02013;2.12)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.095</td><td align="center" valign="middle" rowspan="1" colspan="1">1.25(0.81&#x02013;1.91)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.309</td><td align="center" valign="middle" rowspan="1" colspan="1">0.963</td><td align="center" valign="middle" rowspan="1" colspan="1">0.794</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">RERI</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.17(&#x02212;0.84&#x02013;1.18)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">0.29(0.79&#x02013;1.35)</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td><td align="center" valign="middle" rowspan="1" colspan="1">
</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.23(0.36&#x02013;4.17)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.41(0.36&#x02013;5.49)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td></tr></tbody></table><table-wrap-foot><fn><p>Bold indicates statistical significance at 0.05 level. <sup>a</sup> UF included as a continuous variable. <sup>b</sup> Crude model. <sup>c</sup> Adjusted for gender, age, BMI, cigarette smoking, and alcohol drinking.</p></fn></table-wrap-foot></table-wrap></floats-group></article>